Acquisition of Mehar Hospital Zirakpur

August 03, 2026 BSE Limited National Stock Exchange of India Limited P.J. Tower, Exchange Plaza, Dalal Street, Fort, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 544645 SYMBOL: PARKHOSPS Subject: Disclosure under Regulation 30 and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) – Outcome of Board Meeting held on August 03, 2026 Dear Sir/Madam, In continuation of our intimation dated July 29, 2026, and pursuant to the provisions of Regulations 30 and 33 of the Listing Regulations, we wish to inform you that the Board of Directors of Park Medi World Limited (“Company”) in its meeting held today i.e. Monday, August 03, 2026, has inter alia, considered and approved the following items: 1. Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on June 30, 2026. The Financial Results along with the Limited Review Report are enclosed herewith as Annexure-I. 2. Acquisition of “Mehar Hospital-Zirakpur”, owned and operated by Mehar Mediserve LLP. The details as required under the Listing Regulations read with SEBI circular HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026, along with the press release towards the aforesaid acquisition are enclosed as Annexure -II. 3. Variation in the objects of the Initial Public Offer Proceeds as stated in the Prospectus dated December 12, 2025, subject to approval of the Shareholders by way of Postal Ballot and the notice for obtaining shareholders’ approval for the proposed Variation will be sent to the Shareholders of the Company and the Stock Exchanges in due course. Further details of the Proposed Variation will be set out in the explanatory statement forming part of the notice. The meeting of the Board of Directors of the Company commenced at 08:00 A.M. (IST) and concluded at 09:20 A.M. (IST). The financial results will also be available on the Company's website at https://www.parkhospital.in/. This is for your information and records. Thanking you, For and on behalf of Park Medi World Limited Name: Abhishek Kapoor Designation: Company Secretary & Compliance Officer Encl: A/a Annexure - I 1 N o � CHARTERAECDC OUNTANTS HeaOdff ic:e0 -6/U9pp,eG rr ouFnldo Roarn,Pa r atBaagph D,e lhi-1(N1ID0I0A0)7 Phon:e0 11-41041315218219E,9- 0m: a iaclagiw8a@lg6maioml,.o cffi@caegilwsaaosciat.ine s IndepeAnuddeintRtoe rv'iRsee wp oorntt h "eS tatoefmU ennatu dSittaendd FailnoanneRc eisaufollr t s thQeu aretnedrJe udn3 e02 ,0 2o6fP" a rMke dWio rLlidm iptuerds tuota hnRete gul3a3ot fti hoSenE BI (Listing aOnbDdli cislgoasRtueirqoeun isr eRmeegnutlsa2)t0 i1ao5san, ms e,n ded. ToT hBeo aorfDd i recotfo rs ParMke dWio rLlidm ited I.Weh avree vitehwaeec dc ompSatnaytienomgfUe nnatu dSittaenddF ailnoanRneec siuaolflPt asrM ke di WorLlidm i(tte"hdCe o mpafonrty h"qe)u ,ae rntdeoernJ d u 3n0e2, 0 2(6" tshtea teamtetnathce"hr)ee dw ith, beisnugb mbitytt hCeeod m ppaunrys tuota hrneet q uiroefRm eegnutl3sa3o t fSi EoB(nIL isOtbilnigg ations anDdi sclRoesquurier Reemgeunlta2st0)i1 ao5san, ms e,n {dte"hdLe i sRteignugl a2t0i1o5n"s),. 2.ThCeo mpamnayn'asg eirmsee snpteo fo nrps riebplaorfta hSteti aotnie amnce cnotr wdiattnhhrce ee c ognition anmde asurpermiennlctaid ipoldwie ntsn h Ien dAicacno uSnttainn3dg4(a "rIAdnS 3d 4 ""I)n tFeirniamn cial Reporptriensgc"ur,ni dbSeeerdc t1i3oo3nf t hCeo mpaAncit2e,0s 1 r3e awdi trhe lervualinestss ued thereaunondtd heaercr c oupnrtiinncggie pnleaercsac lelipyInt n edadin iadcn o mplwiiaRtnehcg eu l3a3tion oft hLei stRienggu laTthSieto antse.hm abesen etan p prboyvt ehCdeo mpaBnoya'orsfDd i recOtuorrs. responistsioe bx iplraice tosyns c lounts hSieto ant ebmaesonenotd u rre view. 3.Wec onduocurtree vdoi fte hwSe t ateimanec ncto rwdiattnhhSce te a nodnRa ervdiE enwg age(m"eSnRtEs" ) 241'0R evoifIe nwt eFriinmaI nncfoinnaalpt eirofonr bmyte hIden depAeunddieotnftot hEr en tiitsys'u,e d byt hIen stoiCfth uatreAt cecroeudon fIt nadn(it"asI CAAr Ie"v)oi.fie nwt fienrainmic nifoaml1 caotnisoins ts ofm akiinngq upirriimeoasftr, hi Celo ym papneyr'sso nnelfo rfr mesapnaocnniadsac ilcb olumena ttitnegr s anadp plyinga naodnt ahrleeyrvt piirecowac le Adr uerveiissse. uw b stalneitsniss ac lotlphyeaa nna udit conduicnat cecdo rwdiaStnthca en doanAr uddsis tpiencgui nfideseder c 1t4ilo30 n()o ft hCeo mpaAncite,s 201a3nc do nseqduoeennsott l yeu nsta oob bltea in tahswasetwu oruablnedcc eoa mweao rfae ls li gnificant matttehramsti gbheti dentiinafi nea du dAictc.o rdwiend gonl oyet,x praensa su doipti nion. 4. Baosnoe urdre vcioenwd uacsst teaidtpn ea dr ag3ar baopvhe ,h ancsoo tmtheooi u nargt tetnhtcaiatou ns es ust boe ltihetavhteae c compSatnaytienpmgre enpitaan,rc ecdo rwdiattnhhrce ee c ogannimdte iaosnu rement princliadpioldwe insnt haefo reIsnadiAidca cno uSnttainnadgna odrt dha ecrc oupnrtiinncggie pnleersa lly acceipIntn eddhi anaso, dt i sctlhoiesn efodr mraetqiuotinobr ede ids ciltnoe sreomdfRs e gul3a3ot fti hoen SEB{IL isOtbilnigg aantDdii osncsl Roesquurier eRmeegnutlsa2)t0 i1ao5sna, sm ,e ndiendc,l uding the manniewnr h iicithts bo e d iscloorts hieactdto , n taanimyna st emriisaslt atement. 5.(aA)t teindstr iaotwnton h fa ec tth tahtfie g uforret sht eh rmeoen tehnsd3 e1Md a r2c0h2a 6sr epoirtnt heed Stateamrteehbn eat l anficguibrneegts w aeuednifi tgeuidrr nee ss opfetc hfutel p lr evfiionuasyn ecaainrad l thpeu blyiestahore dfid gauturepe t sot hteh iqruda orftt ehprer evfimoaunsyc eiaTarhlfi.e g uurpet sot he enodft hteh iqruda orftp erre vfiionuasyn echaiaraod ln bleye rne viaenwndeo sdtu bjteoacu tdeidt . (bT)hSet atement infocrtl uhcdeoe rsr etshqpeuo anrerdentisdenJuerguld 3nt 0es2, 0 2a5sr epoirtnt heed previiosusSsutleaydt ewmheiwncethrn, eo s tu btjole icmtri etveide w. FoArg iw&aA ls sociates CharAtcecroeudn tants FRNN0o0:0 181N P.ACg.i wal Partner MemberNsuhmibpe r: PlaGcuer:u gram DatAeu:g 0u3s2,t0 26 UDI2N6:0 80475SIBZRX3355 Annexure-II Details required under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 Sr. no. Particulars Details 1 Name of the target entity, details in brief such as Mehar Mediserve LLP (“Target Entity”) having size, turnover etc LLPIN: AAH-6659. The turnover for the financial year 2025-26 is Rs. 19.10 Crore (Unaudited) 2 Whether the acquisition would fall within related The said transaction does not fall under related party party transaction(s) and whether the promoter/ transaction. promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length” 3 Industry to which the entity being acquired Healthcare / Hospital belongs; 4 Objects and impact of acquisition (including but This proposed acquisition is consistent with the not limited to, disclosure of reasons for acquisition Company's growth strategy of maximizing of target entity, if its business is outside the main operational synergies and achieve economies of scale line of business of the listed entity through the strategic deployment of assets in high- potential markets. 5 Brief details of any governmental or regulatory Not Applicable approvals required for the acquisition 6 Indicative time period for completion of the December 03, 2026 acquisition 7 Consideration - whether cash consideration or share In cash by acquiring 100% stake of the Target Entity swap or any other form and details of the same 8 Cost of acquisition and/or the price at which the INR 107 Crores approx. shares are acquired 9 Percentage of shareholding / control acquired and / 100% stake will be acquired on the date of signing the or number of shares acquired revised Partnership deed. 10 Brief background about the entity acquired in terms The target Entity was incorporated on October 10, of products/line of business acquired, date [Showing first 8,000 characters — download PDF for full document]